 Astrotech Corporation NASDAQ: ASTC announced that the BreathTest-1000TM lung disease screening device that is under development detects a known metabolite that is associated with lung diseases at very low parts per billion ppb concentrations. On March 25, the Company announced that it is working on developing the BreathTest-1000TM to detect volatile organic compound metabolites present in lung diseases such as the Coronavirus COVID-19 and pneumonia. 